INOVIO Aktie

>INOVIO Aktienkurs

0.95 EUR -37.1% (TradegateBSX)

Ask: 0.99 EUR / 5100 Stück

Bid: 0.96 EUR / 12300 Stück

Tagesumsatz: 39856 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

INOVIO Aktie über LYNX handeln

Intraday

1 Jahr

>INOVIO Performance

1 Woche: -32,6%

1 Monat: -34,5%

3 Monate: -35,4%

6 Monate: -53,4%

1 Jahr: -32,6%

laufendes Jahr: -35,8%

>INOVIO Aktie

Name:

INOVIO PHARMACEUTICAL INC

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US45773H4092 / A400EJ

Symbol/ Ticker:

GBM (Frankfurt) / INO (NASDAQ)

Kürzel:

FRA:GBM, ETR:GBM, GBM:GR, NASDAQ:INO

Index:

Webseite:

https://inovio.com/

Profil:

Inovio Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing DNA medicines for treating and protecting against HPV-related diseases, cancer, and infectious diseases. The company employs proprietar..
>Volltext..

Marktkapitalisierung:

104.15 Mio. EUR

Unternehmenswert:

62.32 Mio. EUR

Umsatz:

0.06 Mio. EUR

EBITDA:

-72.63 Mio. EUR

Nettogewinn:

-73.59 Mio. EUR

Gewinn je Aktie:

-1.67 EUR

Schulden:

8.12 Mio. EUR

Liquide Mittel:

38.35 Mio. EUR

Operativer Cashflow:

-76.78 Mio. EUR

Bargeldquote:

1.34

Umsatzwachstum:

-73.55%

Gewinnwachstum:

30.19%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

INOVIO

Letzte Datenerhebung:

05.04.26

>INOVIO Kennzahlen

Aktien/ Unternehmen:

Aktien: 69.09 Mio. St.

Frei handelbar: 99.58%

Leerverk. Aktien: 15.57%

Rückkaufquote: -44.22%

Mitarbeiter: 112

Umsatz/Mitarb.: -

Analysten:

Analystenrating: Buy

Kursziel: 481.15%

Bewertung:

KGV: -

KGV lG: -

KUV: 1815.27

KBV: 3.3

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -4474.06%

Gewinnmarge: -130000%

Operative Marge: -132871.32%

Managementeffizenz:

Gesamtkaprendite: -89.14%

Eigenkaprendite: -183.47%

>INOVIO Peer Group

Gesundheit, Onkologie/ Krebs- Behandlung

>INOVIO Chart & Kurs - NASDAQ

>INOVIO News

04.04.26 - 13:21	INO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 (PR Newswire)
	Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inovio To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inovio between October 10, 2023 and December 26, 2025 and would like to......

03.04.26 - 00:21	INO Deadline: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit (PR Newswire)
	NEW YORK, April 2, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) between October 10, 2023 and December 26, 2025, inclusive (the "Class Period"), of the important April 7, 2026......

02.04.26 - 19:12	Kapitalerhöhung mit Verwässerungseffekt: Inovio-Aktie stürzt ab (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

02.04.26 - 15:09	Inovio prices $17.5 million public offering of shares and warrants (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

02.04.26 - 14:57	INOVIO Announces Pricing of $17.5 Million Public Offering (PR Newswire)
	PLYMOUTH MEETING, Pa., April 2, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced the......

02.04.26 - 08:27	INOVIO Pharmaceuticals proposes securities offering (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

02.04.26 - 02:12	INOVIO Announces Proposed Public Offering (PR Newswire)
	PLYMOUTH MEETING, Pa., April 1, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced......

01.04.26 - 16:33	INOVIO to Participate in Upcoming Scientific Conference (PR Newswire)
	PLYMOUTH MEETING, Pa., April 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will......

01.04.26 - 15:03	Inovio Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 7, 2026 to Discuss Your Rights - INO (PR Newswire)
	NEW YORK, April 1, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Inovio Pharmaceuticals, Inc. ("Inovio Pharmaceuticals, Inc." or the "Company") (NASDAQ: INO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Inovio......

30.03.26 - 21:18	Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
	LOS ANGELES, March 30, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ: INO). IF YOU SUFFERED A LOSS ON......

30.03.26 - 15:06	INO Deadline: INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit (PR Newswire)
	NEW YORK, March 30, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) between October 10, 2023 and December 26, 2025, inclusive (the "Class Period"), of the important April 7, 2026......

30.03.26 - 09:48	INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm (PR Newswire)
	LOS ANGELES, March 30, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inovio Pharmaceuticals, Inc. ("Inovio" or "the Company") (NASDAQ: INO) for violations of §§10(b) and 20(a) of the Securities......

30.03.26 - 09:48	Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO (PR Newswire)
	LOS ANGELES, March 30, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Inovio Pharmaceuticals, Inc. ("Inovio" or "the Company") (NASDAQ: INO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated......

29.03.26 - 14:54	INO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026 (PR Newswire)
	Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inovio To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inovio between October 10, 2023 and December 26, 2025 and would like to......

26.03.26 - 20:51	Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
	BENSALEM, Pa., March 26, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ: INO). IF YOU ARE......

26.03.26 - 08:06	Inovio verfehlt Gewinnprognose für Q4 2025 deutlich – Aktie gibt nach (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

25.03.26 - 22:01	Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
	LOS ANGELES, March 25, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ: INO) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR......

24.03.26 - 16:30	Here′s Why Inovio (INO) Looks Ripe for Bottom Fishing (Zacks)
	Inovio (INO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term....

23.03.26 - 23:54	INO Deadline: INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit (PR Newswire)
	NEW YORK, March 23, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) between October 10, 2023 and December 26, 2025, inclusive (the "Class Period"), of the important April 7, 2026......

22.03.26 - 14:06	INO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 (PR Newswire)
	Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inovio To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inovio between October 10, 2023 and December 26, 2025 and would like to......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Notwendigkeit ist bei weitem stärker als die Kunst. - Aischylos

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram